Quantbot Technologies LP Invests $2.94 Million in Cigna Group $CI

Quantbot Technologies LP purchased a new stake in shares of Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,648 shares of the health services provider’s stock, valued at approximately $2,935,000.

Other hedge funds have also made changes to their positions in the company. Wilkerson Advisory Group LLC purchased a new position in Cigna Group during the 4th quarter worth approximately $25,000. Cedar Mountain Advisors LLC lifted its holdings in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group in the second quarter valued at $29,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group in the fourth quarter worth $29,000. Finally, Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group in the fourth quarter worth $29,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 0.5%

CI stock opened at $276.19 on Monday. The stock has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The company has a 50-day moving average of $284.20 and a two-hundred day moving average of $281.45. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same period in the previous year, the company earned $7.20 earnings per share. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is presently 25.82%.

Analyst Ratings Changes

Several research analysts recently weighed in on CI shares. Mizuho upped their price target on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. The Goldman Sachs Group boosted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Wells Fargo & Company increased their price objective on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Finally, Wolfe Research reissued an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 23,012 shares of company stock valued at $6,386,550. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.